Regulus Therapeutics CEO Joseph Hagan's 2018 pay jumps 22% to $2.3M
Regulus Therapeutics reports 2018 executive compensation
By ExecPay News
Published: July 1, 2019
Regulus Therapeutics reported fiscal year 2018 executive compensation information on July 1, 2019.
In 2018, three executives at Regulus Therapeutics received on average a compensation package of $1.6M, a 33% increase compared to previous year.
Average pay of disclosed executives at Regulus Therapeutics
Joseph P. Hagan, Chief Executive Officer, received $2.3M in total, which increased by 22% compared to 2017. 68% of Hagan's compensation, or $1.6M, was in option awards. Hagan also received $234K in non-equity incentive plan, $520K in salary, as well as $4.3K in other compensation.
Timothy Wright, Chief Research & Development Officer, received a compensation package of $1.5M, which increased by 24% compared to previous year. 55% of the compensation package, or $817K, was in option awards.
Daniel R. Chevallard, Chief Financial Officer, earned $984K in 2018, a 69% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on July 1, 2019.